FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200564982> ?p ?o ?g. }

• W3200564982 endingPage "3089" @default.
• W3200564982 startingPage "3080" @default.
• W3200564982 abstract "Coronavirus disease 2019 (COVID-19) is associated with macro- and micro-thromboses, which are triggered by endothelial cell activation, coagulopathy, and uncontrolled inflammatory response. Conventional antithrombotic agents are under assessment in dozens of randomized controlled trials (RCTs) in patients with COVID-19, with preliminary results not demonstrating benefit in several studies.Given the possibility that more novel agents with antithrombotic effects may have a potential utility for management of patients with COVID-19, we assessed ongoing RCTs including these agents with their potential mechanism of action in this population.We searched clinicaltrials.gov and the World Health Organization International Clinical Trials Registry Platform to identify RCTs of novel antithrombotic agents in patients with COVID-19.Based on a systematic literature search, 27 RCTs with 10 novel antithrombotic agents (including nafamostat, dociparstat, rNAPc2, and defibrotide) were identified. The results from these trials have not been disseminated yet. The studied drugs in the ongoing or completed RCTs include agents affecting the coagulation cascade, drugs affecting endothelial activation, and mixed acting agents. Their postulated antithrombotic mechanisms of action and their potential impact on patient management are summarized.Some novel antithrombotic agents have pleiotropic anti-inflammatory and antiviral effects, which may help reduce the viral load or fibrosis, and improve oxygenation. Results from ongoing RCTs will elucidate their actual role in the management of patients with COVID-19." @default.
• W3200564982 created "2021-09-27" @default.
• W3200564982 creator A5000735539 @default.
• W3200564982 creator A5015399705 @default.
• W3200564982 creator A5021368492 @default.
• W3200564982 creator A5023858070 @default.
• W3200564982 creator A5026738644 @default.
• W3200564982 creator A5032411762 @default.
• W3200564982 creator A5033100094 @default.
• W3200564982 creator A5038405190 @default.
• W3200564982 creator A5040747795 @default.
• W3200564982 creator A5045688475 @default.
• W3200564982 creator A5047198456 @default.
• W3200564982 creator A5061711123 @default.
• W3200564982 creator A5063628237 @default.
• W3200564982 creator A5082464840 @default.
• W3200564982 creator A5088731576 @default.
• W3200564982 creator A5089135981 @default.
• W3200564982 date "2021-12-01" @default.
• W3200564982 modified "2023-10-08" @default.
• W3200564982 title "Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials" @default.
• W3200564982 cites W2035518655 @default.
• W3200564982 cites W2136873165 @default.
• W3200564982 cites W2417803980 @default.
• W3200564982 cites W2769421396 @default.
• W3200564982 cites W3009912996 @default.
• W3200564982 cites W3013514878 @default.
• W3200564982 cites W3017326650 @default.
• W3200564982 cites W3021590393 @default.
• W3200564982 cites W3031710841 @default.
• W3200564982 cites W3040476431 @default.
• W3200564982 cites W3041384178 @default.
• W3200564982 cites W3043084992 @default.
• W3200564982 cites W3044627996 @default.
• W3200564982 cites W3047935199 @default.
• W3200564982 cites W3082240102 @default.
• W3200564982 cites W3087367857 @default.
• W3200564982 cites W3096274861 @default.
• W3200564982 cites W3121071822 @default.
• W3200564982 cites W3124669234 @default.
• W3200564982 cites W3126525609 @default.
• W3200564982 cites W3129013322 @default.
• W3200564982 cites W3136016654 @default.
• W3200564982 cites W3138214175 @default.
• W3200564982 cites W3155392701 @default.
• W3200564982 cites W3172155398 @default.
• W3200564982 cites W3180828297 @default.
• W3200564982 cites W4205922819 @default.
• W3200564982 cites W4231969161 @default.
• W3200564982 doi "https://doi.org/10.1111/jth.15533" @default.
• W3200564982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34538017" @default.
• W3200564982 hasPublicationYear "2021" @default.
• W3200564982 type Work @default.
• W3200564982 sameAs 3200564982 @default.
• W3200564982 citedByCount "11" @default.
• W3200564982 countsByYear W32005649822021 @default.
• W3200564982 countsByYear W32005649822022 @default.
• W3200564982 countsByYear W32005649822023 @default.
• W3200564982 crossrefType "journal-article" @default.
• W3200564982 hasAuthorship W3200564982A5000735539 @default.
• W3200564982 hasAuthorship W3200564982A5015399705 @default.
• W3200564982 hasAuthorship W3200564982A5021368492 @default.
• W3200564982 hasAuthorship W3200564982A5023858070 @default.
• W3200564982 hasAuthorship W3200564982A5026738644 @default.
• W3200564982 hasAuthorship W3200564982A5032411762 @default.
• W3200564982 hasAuthorship W3200564982A5033100094 @default.
• W3200564982 hasAuthorship W3200564982A5038405190 @default.
• W3200564982 hasAuthorship W3200564982A5040747795 @default.
• W3200564982 hasAuthorship W3200564982A5045688475 @default.
• W3200564982 hasAuthorship W3200564982A5047198456 @default.
• W3200564982 hasAuthorship W3200564982A5061711123 @default.
• W3200564982 hasAuthorship W3200564982A5063628237 @default.
• W3200564982 hasAuthorship W3200564982A5082464840 @default.
• W3200564982 hasAuthorship W3200564982A5088731576 @default.
• W3200564982 hasAuthorship W3200564982A5089135981 @default.
• W3200564982 hasBestOaLocation W32005649821 @default.
• W3200564982 hasConcept C126322002 @default.
• W3200564982 hasConcept C168563851 @default.
• W3200564982 hasConcept C177713679 @default.
• W3200564982 hasConcept C2777015399 @default.
• W3200564982 hasConcept C2777408962 @default.
• W3200564982 hasConcept C2777712501 @default.
• W3200564982 hasConcept C2779134260 @default.
• W3200564982 hasConcept C535046627 @default.
• W3200564982 hasConcept C71924100 @default.
• W3200564982 hasConcept C98274493 @default.
• W3200564982 hasConceptScore W3200564982C126322002 @default.
• W3200564982 hasConceptScore W3200564982C168563851 @default.
• W3200564982 hasConceptScore W3200564982C177713679 @default.
• W3200564982 hasConceptScore W3200564982C2777015399 @default.
• W3200564982 hasConceptScore W3200564982C2777408962 @default.
• W3200564982 hasConceptScore W3200564982C2777712501 @default.
• W3200564982 hasConceptScore W3200564982C2779134260 @default.
• W3200564982 hasConceptScore W3200564982C535046627 @default.
• W3200564982 hasConceptScore W3200564982C71924100 @default.
• W3200564982 hasConceptScore W3200564982C98274493 @default.
• W3200564982 hasIssue "12" @default.
• W3200564982 hasLocation W32005649821 @default.

• next